Puma Biotechnology Inc’s Market Journey: Closing Strong at 3.30, Up 14.58

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Puma Biotechnology Inc (NASDAQ: PBYI) was $3.30 for the day, up 14.58% from the previous closing price of $2.88. In other words, the price has increased by $14.58 from its previous closing price. On the day, 1.72 million shares were traded. PBYI stock price reached its highest trading level at $3.48 during the session, while it also had its lowest trading level at $2.93.

Ratios:

Our analysis of PBYI’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.57. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 1.21 whereas as Long-Term Debt/Eq ratio is at 0.50.

Goldman Downgraded its Neutral to Sell on October 08, 2019, whereas the target price for the stock was revised from $24 to $8.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 12 ’24 when MILLER MICHAEL PATRICK sold 23,358 shares for $3.49 per share. The transaction valued at 81,466 led to the insider holds 47,000 shares of the business.

MILLER MICHAEL PATRICK bought 23,358 shares of PBYI for $87,826 on Aug 12 ’24. On Jul 17 ’24, another insider, NOUGUES MAXIMO F, who serves as the Chief Financial Officer of the company, sold 4,156 shares for $3.70 each. As a result, the insider received 15,382 and left with 162,522 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBYI now has a Market Capitalization of 161989408 and an Enterprise Value of 151634352. As of this moment, Puma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.95, and their Forward P/E ratio for the next fiscal year is 9.71. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.63 while its Price-to-Book (P/B) ratio in mrq is 2.28. Its current Enterprise Value per Revenue stands at 0.623 whereas that against EBITDA is 3.4.

Stock Price History:

Over the past 52 weeks, PBYI has reached a high of $7.73, while it has fallen to a 52-week low of $2.22. The 50-Day Moving Average of the stock is 22.84%, while the 200-Day Moving Average is calculated to be -17.15%.

Shares Statistics:

PBYI traded an average of 325.06K shares per day over the past three months and 416160 shares per day over the past ten days. A total of 47.65M shares are outstanding, with a floating share count of 35.19M. Insiders hold about 28.31% of the company’s shares, while institutions hold 56.89% stake in the company. Shares short for PBYI as of 1728950400 were 3615755 with a Short Ratio of 11.12, compared to 1726185600 on 3616406. Therefore, it implies a Short% of Shares Outstanding of 3615755 and a Short% of Float of 8.6899996.

Most Popular